quercetin-3-o-glucuronide and Diabetes-Mellitus--Type-2

quercetin-3-o-glucuronide has been researched along with Diabetes-Mellitus--Type-2* in 1 studies

Other Studies

1 other study(ies) available for quercetin-3-o-glucuronide and Diabetes-Mellitus--Type-2

Article	Year
Investigation into the mechanisms of quercetin-3-O-glucuronide inhibiting α-glucosidase activity and non-enzymatic glycation by spectroscopy and molecular docking. Food & function, 2021, Sep-07, Volume: 12, Issue:17 The inhibition of α-glucosidase and glycation is closely related to the treatment of type 2 diabetes mellitus (DM) and its complications. In this study, quercetin-3-O-glucuronide (Q3GA) showed reversible and mixed-mode inhibition of α-glucosidase activity, with an IC Topics: alpha-Glucosidases; Diabetes Mellitus, Type 2; Furaldehyde; Glycation End Products, Advanced; Glycoside Hydrolase Inhibitors; Glycosylation; Humans; Kinetics; Molecular Docking Simulation; Quercetin	2021

Article

Year

Investigation into the mechanisms of quercetin-3-O-glucuronide inhibiting α-glucosidase activity and non-enzymatic glycation by spectroscopy and molecular docking.

Food & function, 2021, Sep-07, Volume: 12, Issue:17

The inhibition of α-glucosidase and glycation is closely related to the treatment of type 2 diabetes mellitus (DM) and its complications. In this study, quercetin-3-O-glucuronide (Q3GA) showed reversible and mixed-mode inhibition of α-glucosidase activity, with an IC

Topics: alpha-Glucosidases; Diabetes Mellitus, Type 2; Furaldehyde; Glycation End Products, Advanced; Glycoside Hydrolase Inhibitors; Glycosylation; Humans; Kinetics; Molecular Docking Simulation; Quercetin

2021